Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)
1 clinical trials · Condition
◉ Watch Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Milatuzumab for Graft Versus Host Disease (NCT01663766) | Gilead Sciences | 2013-12-01 |
Track Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) automatically
Every clearance here is in the API, with alerts when new ones post.